Live from the NIH registry
Studies recruiting near St. Petersburg right now
Top 25 of 1,370 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Safety Harbor, Florida (13.8 mi)
· Sponsor: Medtronic
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Moffitt — Tampa, Florida (16.5 mi)
· Sponsor: Syndax Pharmaceuticals
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders — Tampa, Florida (16.5 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
Advanced Basal Cell Carcinoma
EARLY/Phase 1
Interventional 34 participants sought
Moffitt Cancer Center — Tampa, Florida (16.5 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Johns Hopkins All Children's Hospital — St. Petersburg, Florida (1.8 mi)
· Sponsor: National Cancer Institute (NCI)
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 90 participants sought
Moffitt Cancer Center — Tampa, Florida (16.5 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 24 participants sought
Moffitt Cancer Center — Tampa, Florida (16.5 mi)
· Sponsor: M.D. Anderson Cancer Center
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Chronic Graft-versus-host Disease (cGVHD)
Phase 2
Interventional 120 participants sought
Moffitt Cancer Center — Tampa, Florida (16.5 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
University of Florida — Tampa, Florida (16.5 mi)
· Sponsor: Westat
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Moffitt Cancer Center-McKinley Campus — Tampa, Florida (16.5 mi)
· Sponsor: Hoffmann-La Roche
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
USF Diabetes and Endocrinology Center — Tampa, Florida (16.5 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
Moffitt Cancer Center /ID# 279068 — Tampa, Florida (16.5 mi)
· Sponsor: AbbVie
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Florida Cancer Specialists - North — St. Petersburg, Florida (1.8 mi)
· Sponsor: Immuneering Corporation
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
Sleep Apnea, Chronic Nasal Congestion
Phase 4
Interventional 52 participants sought
Usf Asthma Allergy and Immunology Cru — Tampa, Florida (16.5 mi)
· Sponsor: University of South Florida
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Clearwater, Florida (14.5 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID)
Hearing Loss, Conductive, Hearing Loss, Mixed
N/A
Observational 50 participants sought
Department of USF Health Otolaryngology; Auditory Rehabilitation & Clinical Trials Lab — Tampa, Florida (16.5 mi)
· Sponsor: University of South Florida
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
Comprehensive Hematology Oncology — St. Petersburg, Florida (1.8 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Johns Hopkins All Children's Hospital — St. Petersburg, Florida (1.8 mi)
· Sponsor: The University of Texas Health Science Center, Houston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Lee Moffitt Cancer Center — Tampa, Florida (16.5 mi)
· Sponsor: Revolution Medicines, Inc.
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Florida Cancer Specialists - North ( Site 7002) — St. Petersburg, Florida (1.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — St. Petersburg, Florida (1.8 mi)
· Sponsor: Daiichi Sankyo
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
University of South Florida (USF) - University of South Florida College of Medicine - Parkinson's Di — Tampa, Florida (16.5 mi)
· Sponsor: Annovis Bio Inc.
A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function
Healthy
Phase 1
Interventional 26 participants sought
Genesis Clinical Research — Tampa, Florida (16.5 mi)
· Sponsor: Pfizer
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Severe Asthma
Phase 2
Interventional 512 participants sought
Research site — Tampa, Florida (16.5 mi)
· Sponsor: Kinaset Therapeutics Inc
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Primary Progressive Multiple Sclerosis, Primary Progressive MS
Phase 2
Interventional 20 participants sought
Local Institution - Site 103 — Tampa, Florida (16.5 mi)
· Sponsor: Sundance Biosciences, Inc.